The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Resistance of young gelatinase B–deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
Open accessAbstract
Matrix metalloproteinases (MMPs) are involved in various physiological (1-5) as well as pathological (6-17) processes.Gelatinases belong to the secreted matrix metalloproteinases and constitute a terminal step in the enzyme cascade that processes extracellular matrices including basement membranes (18-20).Two types are distinguished: gelatinase A (MMP-2) and gelatinase B (MMP-9) (Figure 1a).The former has a molecular weight of 65-75 kDa, lacks a collagen-like domain and is, in general, constitutively present in all body fluids.The latter is inducible and has a molecular weight of more than 85 kDa.The MMPs are synthesized as zymogen-like latent precursors and are converted subsequently to the active form of the zinc proteases by the cysteine switch mechanism (21).In terms of protein and domain structure, gelatinase B is the largest and most complex member identified so far.From in vitro studies, it has been deduced that gelatinase B expression is characterized by a complex regulation with tight control at several levels, e.g., gene transcription and protein secretion by cytokines and chemokines (8,19,(22)(23)(24), action of tissue inhibitors of matrix metalloproteinases (TIMPs) (18, 25, 26), and proenzyme activation by components of the plasminogen activation system (19,20,22,27) or other MMPs (28).The possible functions of this enzyme cascade, including gelatinase B, in central nervous system (CNS) inflammation may be manifold (19,22,29): cleavage of myelin proteins (30-32), degradation of collagen IV in the basement membranes (33, 34), activation or degradation of disease-modifying cytokines (35), and direct damage of CNS cells.Gelatinase B has been detected in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis (MS), and other inflammatory neurologic diseases, but not in normal control patients, whereas gelatinase A was constitutively present in all samples (10, 11).Immunohistochemical reaction with gelatinase B-specific mAb's (36) was documented within human MS plaques in concert with the expression of other metallo-and serine proteases and specific inhibitors (13).Experimental autoimmune encephalomyelitis (EAE) is used as an animal model for MS.However, there exist many variants of EAE depending on the animal species
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475 · cited 2×
“The MMPs are synthesized as zymogen-like latent precursors and are converted subsequently to the active form of the zinc proteases by the cysteine switch mechanism (21).”
BackgroundECM and Cell Surface Proteolysis: Regulating Cellular Ecology
Werb, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80429-8 · Cited by 1,307
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681
Matrix metalloproteinases and diseases of the CNS
Wee Yong, V., Forsyth, P. A., Bell, R., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 639
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., & Matrisian, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1402 · Cited by 609
The Matrix Metalloproteinases and Their Inhibitors
Murphy, G., & Docherty, A. J. P. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.2.120 · Cited by 597
Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice.
Shipley, J. M., Wesselschmidt, R. L., Kobayashi, D. K., Ley, T. J., & Shapiro, S. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3942 · Cited by 502
T cell gelatinases mediate basement membrane transmigration in vitro.
Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., & Hauser, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4379 · Cited by 492
Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., & Mignatti, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2319 · Cited by 422
Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., & Itohara, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22389 · Cited by 356
Stüve, O., Dooley, N. P., Uhm, J. H., Antel, J. P., Francis, G. S., Yong, V. W., & Williams, G. (1996) · Annals of Neurology · doi:10.1002/ana.410400607 · Cited by 348
Gijbels, K., Galardy, R. E., & Steinman, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117578 · Cited by 339
Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · cited 1×
“metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40).”
BackgroundMakela, M., Salo, T., Uitto, V.-J., & Larjava, H. (1994) · Journal of Dental Research · doi:10.1177/00220345940730080201 · Cited by 327
Matrix metalloproteinases degrade myelin basic protein
Chandler, S., Coates, R., Gearing, A., Lury, J., Wells, G., & Bone, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12173-0 · Cited by 294
Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., & Linington, C. (1994) · Annals of Neurology · doi:10.1002/ana.410360714 · Cited by 292
Leppert, D., Waubant, E., Bürk, M. R., Oksenberg, J. R., & Hauser, S. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400606 · Cited by 291
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 291
Gijbels, K., Masure, S., Carton, H., & Opdenakker, G. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90192-n · Cited by 281
Self-citationRosenberg, G. A., Dencoff, J. E., Correa, N., Reiners, M., & Ford, C. C. (1996) · Neurology · doi:10.1212/wnl.46.6.1626 · Cited by 278
Cuzner, M. L., & Opdenakker, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00241-0 · Cited by 268
Self-citationMASURE, S., PROOST, P., VAN DAMME, J., & OPDENAKKER, G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16027.x · Cited by 254
Self-citationCuzner, M. L., Gveric, D., Strand, C., Loughlin, A. J., Paemen, L., Opdenakker, G., & Newcombe, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199612000-00002 · Cited by 251
Self-citationGelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid
Liu, Z., Michael Shipley, J., Vu, T. H., Zhou, X., Diaz, L. A., Werb, Z., & Senior, R. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.475 · Cited by 243
Swanborg, R. H. (1995) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(95)90130-2 · Cited by 217
Hua, J., & Muschel, R. J. (1996) · PubMed · Cited by 211
Cytokine-regulated proteases in autoimmune diseases
Opdenakker, G., & Damme, J. V. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90151-1 · Cited by 210
Self-citationJohnatty, R. N., Taub, D. D., Reeder, S. P., Turcovski-Corrales, S. M., Cottam, D. W., Stephenson, T. J., & Rees, R. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2327 · Cited by 205
Clements, J. M., Cossins, J. A., Wells, G. M. A., Corkill, D. J., Helfrich, K., Wood, L. M., Pigott, R., Stabler, G., Ward, G. A., Gearing, A. J. H., et al. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00210-x · Cited by 205
Mudgett, J. S., Hutchinson, N. I., Chartrain, N. A., Forsyth, A. J., McDonnell, J., Singer, I. I., Bayne, E. K., Flanagan, J., Kawka, D., Shen, C. F., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1<110::aid-art14>3.0.co;2-g · Cited by 205
Gijbels, K., Proost, P., Masure, S., Carton, H., Billiau, A., & Opdenakker, G. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490360409 · Cited by 191
Self-citationEnhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
Cossins, J. A., Clements, J. M., Ford, J., Miller, K. M., Pigott, R., Vos, W., Van Der Valk, P., & De Groot, C. J. A. (1997) · Acta Neuropathologica · doi:10.1007/s004010050754 · Cited by 176
Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein
Proost, P., Vandamme, J., & Opdenakker, G. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1540 · Cited by 176
Self-citationGelatinase B: Structure, Regulation, and Function
Vu, T. H., & Werb, Z. (1998) · Matrix Metalloproteinases · doi:10.1016/b978-012545090-4/50006-9 · Cited by 168
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
Kieseier, B. (1998) · Brain · doi:10.1093/brain/121.1.159 · Cited by 163
van den Oord, J. J., Paemen, L. R., Opdenakker, G., & Wolf‐Peeters, C. D. (1997) · Europe PMC (PubMed Central) · Cited by 144
Self-citationHewson, A. K., Smith, T., Leonard, J. P., & Cuzner, M. L. (1995) · Inflammation Research · doi:10.1007/bf01796266 · Cited by 144
Ovulation as a Tissue Remodelling Process
TSAFRIRI, A. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0952-7_8 · Cited by 126
Rudolph‐Owen, L. A., Hulboy, D. L., Wilson, C. L., Mudgett, J. S., & Matrisian, L. M. (1997) · Endocrinology · doi:10.1210/en.138.11.4902 · Cited by 121
Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis
Brosnan, C. F., Cammer, W., Norton, W. T., & Bloom, B. R. (1980) · Nature · doi:10.1038/285235a0 · Cited by 112
Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.
Opdenakker, G., Masure, S., Grillet, B. A. M., & Damme, J. V. (1991) · PubMed · Cited by 106
Self-citationWuyts, A., Haelens, A., Proost, P., Lenaerts, J., Conings, R., Opdenakker, G., & Damme, J. V. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1736 · Cited by 104
Self-citationMasure, S., Nys, G., Fiten, P., Damme, J. V., & Opdenakker, G. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18359.x · Cited by 94
Self-citationPaemen, L. R., Martens, E., Masure, S., & Opdenakker, G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.759_a.x · Cited by 92
Self-citationSome Misconceptions about Understanding Autoimmunity through Experiments with Knockouts
Steinman, L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2039 · Cited by 91
Ågren, M. S., Jørgensen, L. N., Andersen, M., Viljanto, J. A., & Gottrup, P. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00556.x · Cited by 84
Paemen, L. R., Olsson, T. P., Söderström, M. B., Damme, J. V., & Opdenakker, G. (1994) · European Journal of Neurology · doi:10.1111/j.1468-1331.1994.tb00051.x · Cited by 76
Self-citationStromelysin-1 (MMP-3)–Independent Gelatinase Expression and Activation in Mice
LIJNEN, H. R., Silence, J., HOEF, B. V., & Collen, D. (1998) · Blood · doi:10.1182/blood.v91.6.2045 · Cited by 55
Mighty mice: Transgenic technology “knocks out” questions of matrix metalloproteinase function
Shapiro, S. D. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90027-5 · Cited by 47
Norga, K., Paemen, L. R., Masure, S., Dillen, C., Heremans, H., Billiau, A., Carton, H., Cuzner, L., Olsson, T. P., Damme, J. V., et al. (1995) · Inflammation Research · doi:10.1007/bf01757357 · Cited by 41
Self-citationBaker, D., O'Neill, J. K., DAVISON, A. N., & Turk, J. L. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05843.x · Cited by 29
Inuzuka, T., Sato, S., Baba, H., & Miyatake, T. (1988) · Neurochemical Research · doi:10.1007/bf00971537 · Cited by 8
(1998) · Europe PMC (PubMed Central)
Cited by
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Self-citationThe blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 778
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Self-citation
Metadata
- Authors
- Dubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hämmerling, G., Opdenakker, G., & Arnold, B.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-12-01
- Volume
- 104
- Issue
- 11
- Pages
- 1507-1515
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2005993855
- Cited by
- 262
- References
- 56
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.